Early Identification of Residual Disease After Neuroendocrine Tumor Resection Using a Liquid Biopsy...
Early Identification of Residual Disease After Neuroendocrine Tumor Resection Using a Liquid Biopsy Multigenomic mRNA Signature (NETest)
About this item
Full title
Author / Creator
Modlin, Irvin M. , Kidd, Mark , Oberg, Kjell , Falconi, Massimo , Filosso, Pier Luigi , Frilling, Andrea , Malczewska, Anna , Salem, Ronald , Toumpanakis, Christos , Laskaratos, Faidon-Marios , Partelli, Stefano , Roffinella, Matteo , von Arx, Claudia , Kudla, Beata Kos , Bodei, Lisa , Drozdov, Ignat A. and Kitz, Alexandra
Publisher
Cham: Springer International Publishing
Journal title
Language
English
Formats
Publication information
Publisher
Cham: Springer International Publishing
Subjects
More information
Scope and Contents
Contents
Introduction
Surgery is the only cure for neuroendocrine tumors (NETs), with R0 resection being critical for successful tumor removal. Early detection of residual disease is key for optimal management, but both imaging and current biomarkers are ineffective post-surgery. NETest, a multigene blood biomarker, identifies NETs with >90% accuracy. We...
Alternative Titles
Full title
Early Identification of Residual Disease After Neuroendocrine Tumor Resection Using a Liquid Biopsy Multigenomic mRNA Signature (NETest)
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_swepub_primary_oai_DiVA_org_uu_469879
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_swepub_primary_oai_DiVA_org_uu_469879
Other Identifiers
ISSN
1068-9265,1534-4681
E-ISSN
1534-4681
DOI
10.1245/s10434-021-10021-1
